PDT Partners’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

PDT Partners’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-418,650	Closed	-$5.21M	–	575
2016 Q4	$5.21M	Sell	418,650 -355,437	-46%	-$4.28M	0.34%	131
2016 Q3	$10.6M	Buy	774,087 +155,900	+25%	+$1.57M	0.62%	19
2016 Q2	$4.57M	Hold	618,187	–	–	0.36%	128
2016 Q1	$3.95M	Buy	618,187 +202,700	+49%	+$1.14M	0.25%	174
2015 Q4	$2.6M	Buy	415,487 +205,687	+98%	+$1.35M	0.36%	129
2015 Q3	$1.23M	Buy	+209,800	New	+$1.62M	0.03%	658
2015 Q2	–	Sell	-224,914	Closed	-$1.85M	–	1835
2015 Q1	$1.85M	Buy	+224,914	New	+$1.66M	0.05%	484
2013 Q4	–	Sell	-49,500	Closed	-$911K	–	1388
2013 Q3	$911K	Buy	+49,500	New	+$961K	0.02%	803

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

PDT Partners's ARIA Position: Q1 2017 in Review

PDT Partners sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 418,650 shares — an estimated $5.21M sold.

PDT Partners first reported a position in ARIA in Q3 2013 and held it in 8 quarters. The position peaked at $10.6M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

PDT Partners reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
PDT Partners sold 418,650 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $5.21M.
PDT Partners first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 8 quarters.
PDT Partners's Ariad Pharmaceuticals Inc position peaked at $10.6M in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on PDT Partners's 13F filing for Q1 2017, filed 15 May 2017.